Medarova Zdravka 13D and 13G filings for TransCode Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-10 08:00 am Purchase |
2022-12-31 | 13G | TransCode Therapeutics, Inc. RNAZ |
Medarova Zdravka | 63 12.700% |
2 (+2.61%) |
Filing |
| 2022-12-19 5:33 pm Purchase |
2021-12-31 | 13G | TransCode Therapeutics, Inc. RNAZ |
Medarova Zdravka | 61 12.500% |
61 (New Position) |
Filing |